1.	Phase II/III Randomized Pilot Study of Fluconazole as Prophylaxis for Mucositis/Thrush in Patients With Head and Neck Cancer Undergoing Radiotherapy Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Completed Age: Over 21 Sponsor: Other Protocol IDs: SCCC-92110, NCI-V93-0288, NCT00002533
2.	Phase III Randomized Study of FK463 Versus Fluconazole in the Prevention of Fungal Infections in Patients Undergoing Autologous or Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 6 months and over Sponsor: NCI Protocol IDs: NCI-00-C-0014, MCC-12202
3.	Phase III Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Fluconazole in the Early Empirical Treatment of Suspected Fungal Infections in Febrile Neutropenic Patients with Leukemia or Lymphoma (Summary Last Modified 07/94) Phase: Phase III Type: Supportive care Status: Completed Age: at least 2 years Sponsor: NCI Protocol IDs: NCI-88-C-154A, NCI-T88-0184N, T88-0184
4.	Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)(COMPLETED) Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01899, NCT00044486
5.	Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 2 to 12 Sponsor: NCI, NHLBI Protocol IDs: 416, BMTCTN-0101, UF-G-074-2003, FHCRC-1808.00, CDR0000349374, U01 HL069294, NCT00075803
6.	Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: NCI, Other Protocol IDs: 1322.00, FHCRC-1322.00, NCI-H99-0030, CDR0000067050, NCT00003883
7.	Phase I Study of Voriconazole versus Fluconazole in Patients with Hematologic Malignancies, Hematologic Conditions, or Solid Tumors at Risk for Aspergillosis (Summary Last Modified 10/98) Phase: Phase I Type: Supportive care Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MCV-CCHR-9603-2H, PFIZER-95CK39-0673, NCI-G97-1325
8.	Phase I Pharmacokinetic Study of Fluconazole in Pediatric Cancer Patients (Summary Last Modified 06/97) Phase: Phase I Type: Supportive care Status: Completed Age: 5 to 15 Sponsor: NCI Protocol IDs: NCI-89-C-24, NCI-T89-0047N, T89-0047
9.	Randomized Study of Fluconazole vs Clotrimazole Troches in the Treatment of Patients with Oropharyngeal Thrush in Association with Malignancy (Summary Last Modified 07/90) Phase: No phase specified Type: Supportive care Status: Closed Age: 13 and over Sponsor: Protocol IDs: ICC-88N3, NCI-V89-0117
10.	Study of Fluconazole vs Nystatin in the Prevention of Fungal Infections in Neutropenic Pediatric Patients Undergoing Chemotherapy for Malignancy (Summary Last Modified 09/91) Phase: No phase specified Type: Supportive care Status: Closed Age: 2 to 13 Sponsor: NCI Protocol IDs: CCG-S901
11.	An Open, Multicenter, Comparative Study of the Efficacy, Safety, and Tolerance of Fluconazole vs Itraconazole in the Treatment of Cancer Patients with Oropharyngeal Candidiasis (Summary Last Modified 09/92) Phase: No phase specified Type: Supportive care Status: Closed Age: 16 and over Sponsor: Protocol IDs: EORTC-19911
12.	Blood and Marrow Transplant Clinical Research Network Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: 2 and over Sponsor: NHLBI Protocol IDs: 139, NCT00023530